215 related articles for article (PubMed ID: 16484652)
1. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population.
Czaplinski A; Yen AA; Appel SH
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):390-2. PubMed ID: 16484652
[TBL] [Abstract][Full Text] [Related]
2. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
[TBL] [Abstract][Full Text] [Related]
3. Motor responses of the sternocleidomastoid muscle in patients with amyotrophic lateral sclerosis.
Pinto S; de Carvalho M
Muscle Nerve; 2008 Oct; 38(4):1312-7. PubMed ID: 18785186
[TBL] [Abstract][Full Text] [Related]
4. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
[TBL] [Abstract][Full Text] [Related]
5. Amyotrophic lateral sclerosis: early predictors of prolonged survival.
Czaplinski A; Yen AA; Appel SH
J Neurol; 2006 Nov; 253(11):1428-36. PubMed ID: 16773270
[TBL] [Abstract][Full Text] [Related]
6. Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis.
Capozzo R; Quaranta VN; Pellegrini F; Fontana A; Copetti M; Carratù P; Panza F; Cassano A; Falcone VA; Tortelli R; Cortese R; Simone IL; Resta O; Logroscino G
J Neurol; 2015 Mar; 262(3):593-603. PubMed ID: 25522696
[TBL] [Abstract][Full Text] [Related]
7. Correlation between Forced Vital Capacity and Slow Vital Capacity for the assessment of respiratory involvement in Amyotrophic Lateral Sclerosis: a prospective study.
Pinto S; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):86-91. PubMed ID: 27915482
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
[TBL] [Abstract][Full Text] [Related]
9. Effects of early introduction of non-invasive positive pressure ventilation based on forced vital capacity rate of change: Variation across amyotrophic lateral sclerosis clinical phenotypes.
Elamin EM; Wilson CS; Sriaroon C; Crudup B; Pothen S; Kang YC; White KT; Anderson WM
Int J Clin Pract; 2019 Jan; 73(1):e13257. PubMed ID: 30230161
[TBL] [Abstract][Full Text] [Related]
10. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
Pastula DM; Moore DH; Bedlack RS
Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
[TBL] [Abstract][Full Text] [Related]
11. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
Pinto S; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
[TBL] [Abstract][Full Text] [Related]
12. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?
Czaplinski A; Yen AA; Simpson EP; Appel SH
Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741
[TBL] [Abstract][Full Text] [Related]
13. Assessment of respiratory functions by spirometry and phrenic nerve studies in patients of amyotrophic lateral sclerosis.
Singh D; Verma R; Garg RK; Singh MK; Shukla R; Verma SK
J Neurol Sci; 2011 Jul; 306(1-2):76-81. PubMed ID: 21496826
[TBL] [Abstract][Full Text] [Related]
14. Classifying Patients with Amyotrophic Lateral Sclerosis by Changes in FVC. A Group-based Trajectory Analysis.
Ackrivo J; Hansen-Flaschen J; Jones BL; Wileyto EP; Schwab RJ; Elman L; Kawut SM
Am J Respir Crit Care Med; 2019 Dec; 200(12):1513-1521. PubMed ID: 31322417
[No Abstract] [Full Text] [Related]
15. Slow vital capacity as a useful indicator of the prognosis after percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis.
Ueno T; Haga R; Arai A; Tomiyama M
Acta Neurol Scand; 2022 Nov; 146(5):578-585. PubMed ID: 35975358
[TBL] [Abstract][Full Text] [Related]
16. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis.
Fitting JW; Paillex R; Hirt L; Aebischer P; Schluep M
Ann Neurol; 1999 Dec; 46(6):887-93. PubMed ID: 10589541
[TBL] [Abstract][Full Text] [Related]
17. The ALSFRSr predicts survival time in an ALS clinic population.
Kaufmann P; Levy G; Thompson JL; Delbene ML; Battista V; Gordon PH; Rowland LP; Levin B; Mitsumoto H
Neurology; 2005 Jan; 64(1):38-43. PubMed ID: 15642901
[TBL] [Abstract][Full Text] [Related]
18. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: a six-month longitudinal study.
de Carvalho M; Swash M
Muscle Nerve; 2010 Feb; 41(2):208-11. PubMed ID: 19697379
[TBL] [Abstract][Full Text] [Related]
20. Measures of dyspnea in patients with amyotrophic lateral sclerosis.
Lechtzin N; Lange DJ; Davey C; Becker B; Mitsumoto H
Muscle Nerve; 2007 Jan; 35(1):98-102. PubMed ID: 17029274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
